Iohexol Plasma Clearance Measurement Protocol Standardization for Adults - a Consensus Paper of the European Kidney Function Consortium.

consensus document exogenous filtration marker iohexol measured GFR one-compartment model protocol standardization

Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
01 Aug 2024
Historique:
received: 20 02 2024
revised: 10 06 2024
accepted: 14 06 2024
medline: 4 8 2024
pubmed: 4 8 2024
entrez: 3 8 2024
Statut: aheadofprint

Résumé

International consensus supports the development of standardized protocols for measured glomerular filtration rate (mGFR) to facilitate the integration of mGFR testing in both clinical and research settings. To this end, the European Kidney Function Consortium convened an international group of experts with relevant experience in mGFR. The working group performed an extensive literature search to inform the development of recommendations for mGFR determination using one-compartment plasma clearance models and iohexol as the exogenous filtration marker. Iohexol was selected as it is non-radio labeled, inexpensive, safe, can be assayed at a central laboratory, and the other commonly used non-radio labeled tracers have been (inulin) or are soon to be (iothalamate) discontinued. A plasma clearance model was selected over urine clearance as it requires no urine collection. A one-compartment was preferred to two compartments as it requires fewer samples. The recommendations are based on published evidence complemented by expert opinion. The consensus paper covers practical advice for patients and health professionals, preparation, administration and safety aspects of iohexol, laboratory analysis, blood sample collection and sampling times using both multiple and single sample protocols, description of the mGFR mathematical calculations as well as implementation strategies. Supplementary materials include patient and provider information sheets, standard operating procedures, a study protocol template, and support for mGFR calculation.

Identifiants

pubmed: 39097002
pii: S0085-2538(24)00537-4
doi: 10.1016/j.kint.2024.06.029
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

Andrew Goss (A)
Katerina Luxemburgová (K)
Ulf Nyman (U)
Muhammad Barghouth (M)

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Natalie Ebert (N)

Charité Universitätsmedizin Berlin, Institute of Public Health, Berlin, Germany.

Elke Schaeffner (E)

Charité Universitätsmedizin Berlin, Institute of Public Health, Berlin, Germany.

Jesse C Seegmiller (JC)

Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN.

Marco van Londen (M)

Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands.

Arend Bökenkamp (A)

Emma Children's Hospital, Amsterdam UMC, Amsterdam, The Netherlands.

Etienne Cavalier (E)

Departments of Clinical Chemistry and.

Pierre Delanaye (P)

Nephrology-Dialysis-Transplantation University of Liège, Centre Hospitalier Universitaire du Sart-Tilman, Liège (ULiege), Belgium; Department of Nephrology-Dialysis-Apheresis, Hôpital Universitaire Carémeau, Nîmes, France.

Laurence Derain-Dubourg (L)

Service de Néphrologie, Dialyse, Hypertension et Exploration Fonctionnelle Rénale, Centre de Référence des Maladies Rénales Rares MAREGE, filière maladies rares ORKID, Hôpital E. Herriot, Hospices Civils de Lyon, Lyon, France.

Bjørn O Eriksen (BO)

the Section of Nephrology, University Hospital of North Norway and Metabolic and Renal Research Group, UiT, The Arctic University of Norway, Tromsø, Norway.

Olafur S Indridason (OS)

Division of Nephrology, Landspitali University Hospital, Reykavik, Iceland.

Runolfur Palsson (R)

Division of Nephrology, Landspitali University Hospital, Reykavik, Iceland; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Tariq Shafi (T)

Division of Kidney Diseases, Hypertension & Transplantation, Department of Medicine, Houston Methodist Hospital, Houston, USA.

Anders Christensson (A)

Department of Nephrology, Skåne University Hospital, Lund University, Malmö, Sweden.

Sebastjan Bevc (S)

Department of Nephrology, Department of Pharmacology, University Medical Centre Maribor, Faculty of Medicine, University of Maribor, Maribor, Slovenia.

Fabiola Carrara (F)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.

Marie Courbebaisse (M)

Université Paris Cité; Physiology Department, Hôpital Européen Georges-Pompidou, APHP; INEM, INSERM U1151. Paris, France.

R Neil Dalton (RN)

Evelina London Children's Hospital, London, United Kingdom.

Markus van der Giet (M)

Department of Nephrology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Toralf Melsom (T)

the Section of Nephrology, University Hospital of North Norway and Metabolic and Renal Research Group, UiT, The Arctic University of Norway, Tromsø, Norway.

Shona Methven (S)

Department of Renal Medicine, Aberdeen Royal Infirmary, Scotland, UK.

Gunnar Nordin (G)

Equalis AB, Uppsala, Sweden.

Hans Pottel (H)

Department of Public Health and Primary Care, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.

Andrew D Rule (AD)

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.

Matias Trillini (M)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.

Christine A White (CA)

Department of Medicine, Queen's University, Kingston, Ontario, Canada. Electronic address: cw38@queensu.ca.

Classifications MeSH